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During the reproduction process of Table 4 on page 267 of this article, errors were inadvertently introduced. In the right hand columns
f Table 4, the 95% conﬁdence intervals and p-values were transcribed incorrectly. The corrected Table 4 is shown below.
The publisher would like to apologize for any inconvenience this may  have caused to the authors of this article and readers of the
ournal.
able 4
nivariate and multivariate logistic regression analyses for peri-procedural myocardial injury.
Variable  Univariate  Multivariate
Odds  ratio  95%  Conﬁdence  interval  P  Odds  ratio  95%  Conﬁdence  interval  P
Age  0.99  0.97–1.02  0.547
Male 0.65  0.33–1.25  0.195  0.69  0.34–1.43  0.320
Body mass  index  1.04  0.96–1.12  0.318
Hypertension 0.85  0.44–1.64  0.630
Diabetes 0.84  0.48–1.45  0.531
Current smoker  0.98  0.53–1.82  0.954
Multiple vessel  disease  1.69  0.97–2.96  0.065  1.42  0.78–2.61  0.256
LDL-C 1.01  1.00–1.02  0.159  1.01  1.00–1.02  0.045
HDL-C 1.01  0.99–1.03  0.532
HemoglobinA1c 0.91  0.70–1.20  0.517
High sensitivity
C-reactive  protein  0.89  0.66–1.20  0.430
ACE-I and/or  ARB  1.00  0.57–1.74  0.997
Calcium channel  blockers  0.65  0.38–1.13  0.128  0.70  0.40–1.25  0.231
Beta-blockers 1.09  0.58–2.02  0.797
Nitrates 1.44  0.75–2.78  0.273
Complex lesion  (type  B2/Ca)  1.81  1.04–3.15  0.036  1.55  0.84–2.87  0.162
Reference vessel  diameter  0.89  0.56–1.40  0.604  0.95  0.56–1.60  0.843
Lesion length  1.02  0.96–1.07  0.608  0.97  0.90–1.04  0.344
Direct stenting  1.66  0.75–3.67  0.211
Number of stent  1.23  0.68–2.21  0.501
Stent size  0.51  0.27–0.98  0.044  0.91  0.39–2.14  0.833
Total stent  length  1.02  0.99–1.04  0.150  1.00  0.97–1.03  0.893
Maximum inﬂation  pressure  1.02  0.95–1.12  0.546
Total Balloon  inﬂation  time  1.00  0.99–1.01  0.817
DES use  2.38  1.34–4.23  0.003  2.49  1.09–5.70  0.031
DL-C,  low-density  lipoprotein  cholesterol;  HDL-C,  high-density  lipoprotein  cholesterol;  ACE-I,  angiotensin  converting  enzyme  inhibitors;  ARB,  angiotensin  II  receptor  blockers;  DES,  drug-eluting  stent.
a Lesion  type  was  classiﬁed  according  to  American  Heart  Association/American  College  of  Cardiology  deﬁnition.
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